David A. Siegel Bausch Health Companies Inc. Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 287,839 shares of BHC stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287,839

Previous 307,600 6.42%

Holding current value

$1.4 Million

Previous $2.48 Million 24.89%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$6.16 - $7.94 $121,727 - $156,902	-19,761 Reduced 6.42%	287,839 $1.86 Million
Q4 2024 Feb 14, 2025	BUY	$7.34 - $9.78 $1.67 Million - $2.22 Million	227,400 Added 283.54%	307,600 $2.48 Million
Q3 2024 Nov 14, 2024	BUY	$5.22 - $8.26 $358,092 - $566,636	68,600 Added 591.38%	80,200 $653,000
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $150,060 - $256,086	-24,600 Reduced 67.96%	11,600 $80,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $334,887 - $457,291	-43,100 Reduced 54.35%	36,200 $384,000
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $54,199 - $68,309	-8,300 Reduced 9.47%	79,300 $635,000
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $164,566 - $207,794	-21,400 Reduced 19.63%	87,600 $720,000
Q2 2023 Aug 14, 2023	SELL	$5.72 - $8.8 $262,548 - $403,920	-45,900 Reduced 29.63%	109,000 $872,000
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $366,752 - $575,240	-58,400 Reduced 27.38%	154,900 $1.25 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $307,545 - $400,465	-50,500 Reduced 19.14%	213,300 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $328,844 - $661,278	-71,800 Reduced 21.39%	263,800 $1.82 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.22 Million - $4.07 Million	-172,200 Reduced 33.91%	335,600 $2.81 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $4.38 Million - $5.64 Million	202,800 Added 66.49%	507,800 $11.6 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $6.37 Million - $8.03 Million	-276,800 Reduced 47.58%	305,000 $8.42 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $17.1 Million - $20.5 Million	-682,600 Reduced 53.99%	581,800 $16.2 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $17.8 Million - $21.2 Million	648,000 Added 105.13%	1,264,400 $37.1 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $7.9 Million - $12.7 Million	369,900 Added 150.06%	616,400 $19.6 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $3.46 Million - $4.78 Million	-226,100 Reduced 47.84%	246,500 $5.13 Million
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $5.14 Million - $6.95 Million	-345,300 Reduced 42.22%	472,600 $7.34 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $491,139 - $756,819	-36,900 Reduced 4.32%	817,900 $15 Million
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1.92 Million - $4.47 Million	-147,700 Reduced 14.73%	854,800 $13.2 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $9.36 Million - $15.8 Million	495,382 Added 97.69%	1,002,500 $30 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $34.4 Million - $42.3 Million	-1,647,200 Reduced 76.46%	507,118 $11.1 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $10.9 Million - $14.1 Million	-532,029 Reduced 19.8%	2,154,318 $54.3 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $28.5 Million - $37.1 Million	1,409,579 Added 110.4%	2,686,347 $66.4 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $12.9 Million - $20.7 Million	730,250 Added 133.62%	1,276,768 $23.6 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $11.3 Million - $14 Million	546,518 New	546,518 $14 Million

Others Institutions Holding BHC

# of Institutions

271

Shares Held

243M

Call Options Held

3.66M

Put Options Held

11.3M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.76B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account